We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

7 hedge funds and large institutions have $9.5K invested in Zomedica Corp. in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less funds holding

Funds holding: 87 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

92% less capital invested

Capital invested by funds: $123K → $9.5K (-$113K)

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ZOM Hedge Fund Activity: Q2 2026 in Review

7 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2026, worth a combined $9.5K — down 92% from $123K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ZOM and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was EverSource Wealth Advisors, opening a new position worth an estimated $100. The largest seller was Jackson Wealth Management, exiting entirely with an estimated $76K sold.

  • 7 institutional investors held Zomedica Corp. (ZOM) as of Q2 2026, down from 8 in Q1 2026.
  • Funds reported $9.5K of Zomedica Corp. stock for Q2 2026, down 92% quarter-over-quarter.
  • 2 funds opened new Zomedica Corp. positions in Q2 2026 and 3 closed out, a net change of -1 holder.
  • The largest Zomedica Corp. buyer in Q2 2026 was EverSource Wealth Advisors, an estimated $100 added.
  • The largest Zomedica Corp. seller in Q2 2026 was Jackson Wealth Management, an estimated $76K sold.

Based on aggregated 13F filings for Q2 2026.